Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
02 juin 2024 18h43 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, June 03, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License...
Lynch Carpenter Investigates Claims in Sav-RX Data Breach
31 mai 2024 17h21 HE
|
Lynch Carpenter
PITTSBURGH, May 31, 2024 (GLOBE NEWSWIRE) -- Sav-Rx recently announced that it suffered from a cybersecurity attack in October of 2023, which impacted the personal information of approximately 2.8...
Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034: Rising Opportunities for IBD Drugs in Asian Markets
31 mai 2024 06h32 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Inflammatory...
Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer
30 mai 2024 18h49 HE
|
Telix Pharmaceuticals Limited
TLX591 is an investigational anti-PSMA1 radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of mCRPC, differentiated by a short two-week dosing regimen.Reported median...
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
30 mai 2024 17h55 HE
|
Myriad Genetics, Inc.
Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA-approved...
Psoriasis Drugs Market (2023-2034) to Grow by $28.85 Billion - Global and Regional Growth Opportunities for Hospital, Retail, and Online Pharmacies with Profiles of the Top 10+ Market Players
30 mai 2024 06h13 HE
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Global Psoriasis Drugs Market" report has been added to ResearchAndMarkets.com's offering.The global psoriasis drugs market accounted for USD 12.41...
Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
29 mai 2024 13h46 HE
|
Lynch Carpenter
PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Cencora, Inc. recently announced that it suffered from a cybersecurity attack that occurred in February of 2024, which impacted the personal information...
Allergic Rhinitis Drugs Market Report 2024-2034: Launch of Effective and Novel Drug Delivery Systems Spurs Adoption, Growing Awareness About Treatment Options
29 mai 2024 04h16 HE
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Allergic Rhinitis Drugs Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.Allergic Rhinitis Drugs Market will surpass...
Telix Submits NDA for New Prostate Cancer Imaging Agent
28 mai 2024 07h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, May 28, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States...
Benzoic Acid Market Is Expected To Reach A Revenue Of USD 1,853.5 Mn By 2033, At 5.3% CAGR: Dimension Market Research
27 mai 2024 10h48 HE
|
Dimension Market Research
New York, May 27, 2024 (GLOBE NEWSWIRE) -- Market Overview Global Benzoic Acid Market size is expected to reach USD 1,164.6 million by 2024 and is further anticipated to reach USD 1,853.5...